Birchview Capital »

Apogee Therapeutics shares owned by Birchview Capital

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Birchview Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $636k 16k 39.73
2025-06-30 $695k 16k 43.43
2025-03-31 $299k 8.0k 37.36